inclusion criteria: able to give informed consent. male or female, age > 18 years. female patients of childbearing age must confirm their intention not to fall pregnant during the study period of 6 weeks. a clinical diagnosis of long covid a fatigue score of ≥ 5 on the c19-yrs first assessment a self-reported fatigue score on the c19-yrs ≥ 2 points more severe than their pre-covid baseline more than 12 weeks following a positive covid-19 swab test (lateral flow or pcr) or an illness in keeping with covid-19 infection in the opinion of the chief investigator, despite the absence of swab confirmation (not tested or test negative). where applicable, have completed any other therapeutic rehabilitation intervention for long covid-related fatigue. willing and able to attend for a course of 6 once per week acupuncture treatments co-existing reversible causes of fatigue and/or breathlessness medically optimized if a patient has ongoing breathlessness a chest x-ray should have been performed if on steroids should be on stable dose for at least two weeks at time of study entry if taking other dietary/vitamin interventions should be on a stable regimen for at least two weeks at the time of study entry if vaccinated should be a least two weeks post last vaccine dose or booster participants with a history of cancer must be on a stable dose of treatments such as oral tkis, or antiestrogen therapies or be more than 2 years from diagnosis and completion of radical treatment where applicable, participants on aspirin, clopidogrel or oral anticoagulants are on a stable dose and discussed with the acupuncture clinician (dr jacqueline filshie or a suitably qualified member of her team) before study entry

inclusion criteria: able to give informed consent. male or female, age > 18 years. female patients of childbearing age must confirm their intention not to fall pregnant during the study period of 6 weeks. a clinical diagnosis of long covid a fatigue score of ≥ 5 on the c19-yrs first assessment a self-reported fatigue score on the c19-yrs ≥ 2 points more severe than their pre-covid baseline more than 12 weeks following a positive covid-19 swab test (lateral flow or pcr) or an illness in keeping with covid-19 infection in the opinion of the chief investigator, despite the absence of swab confirmation (not tested or test negative). where applicable, have completed any other therapeutic rehabilitation intervention for long covid-related fatigue. willing and able to attend for a course of 6 once per week acupuncture treatments co-existing reversible causes of fatigue and/or breathlessness medically optimized if a patient has ongoing breathlessness a chest x-ray should have been performed if on steroids should be on stable dose for at least two weeks at time of study entry if taking other dietary/vitamin interventions should be on a stable regimen for at least two weeks at the time of study entry if vaccinated should be a least two weeks post last vaccine dose or booster participants with a history of cancer must be on a stable dose of treatments such as oral tkis, or antiestrogen therapies or be more than 2 years from diagnosis and completion of radical treatment where applicable, participants on aspirin, clopidogrel or oral anticoagulants are on a stable dose and discussed with the acupuncture clinician (dr jacqueline filshie or a suitably qualified member of her team) before study entry

inclusion criteria: able to give informed consent male or female, age > 18 years female patients of childbearing age must confirm their intention not to fall pregnant during the study period of 6 weeks for the clinical diagnosis of long covid a fatigue score of ≥ 5 on the c19-yrs first assessment and a self-reported fatigue score on the c19-yrs ≥ 2 points more severe than their pre-covid baseline more than 12 weeks following a positive covid-19 swab test (lateral flow or pcr) or an illness in keeping with covid-19 infection in the opinion of the chief investigator, despite the absence of swab confirmation (not tested or test negative) if applicable, have completed any other therapeutic rehabilitation intervention for long covid-related fatigue. willing and able to attend for a course of 6 once per week acupuncture treatments co-existing reversible causes of fatigue and/or breathlessness medically optimized if a patient has ongoing breathlessness a chest x-ray should have been performed if on steroids should be on stable dose for at least two weeks at time of study entry if taking other dietary/vitamin interventions should be on a stable regimen for at least two weeks at the time of study entry if vaccinated should be a least two weeks post second dose participants may have a diagnosis of cancer if on a stable dose of treatments such as oral tkis, or antiestrogen therapies participants may have had a diagnosis of cancer if more than 2 years from diagnosis and completion of radical treatment

inclusion criteria: able to give informed consent male or female, age > 18 years female patients of childbearing age must confirm their intention not to fall pregnant during the study period of 6 weeks for the clinical diagnosis of long covid a fatigue score of ≥ 5 on the c19-yrs first assessment and a self-reported fatigue score on the c19-yrs ≥ 2 points more severe than their pre-covid baseline more than 12 weeks following a positive covid-19 swab test (lateral flow or pcr) or an illness in keeping with covid-19 infection in the opinion of the chief investigator, despite the absence of swab confirmation (not tested or test negative) if applicable, have completed any other therapeutic rehabilitation intervention for long covid-related fatigue. willing and able to attend for a course of 6 once per week acupuncture treatments co-existing reversible causes of fatigue and/or breathlessness medically optimized if a patient has ongoing breathlessness a chest x-ray should have been performed if on steroids should be on stable dose for at least two weeks at time of study entry if taking other dietary/vitamin interventions should be on a stable regimen for at least two weeks at the time of study entry if vaccinated should be a least two weeks post second dose participants may have a diagnosis of cancer if on a stable dose of treatments such as oral tkis, or antiestrogen therapies participants may have had a diagnosis of cancer if more than 2 years from diagnosis and completion of radical treatment